• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Anthem, Inc. Aims to Enhance Maternal Health with New Digital-First Solution

    6/7/22 7:55:00 AM ET
    $ANTM
    Medical Specialities
    Health Care
    Get the next $ANTM alert in real time by email

    Anthem partners with Happify Health to bring innovative digital health services to areas of women's health including pregnancy, menopause, and more

    Anthem, Inc. (NYSE:ANTM), a leading health company dedicated to improving lives and communities, will add to its ongoing support of the whole health of women with the addition of a new a digital-first solution in select markets. This program, a collaboration between Anthem – soon to be Elevance Health on June 28 – and Happify Health, bridges the gap between the unique physical and mental health concerns women face. It is part of Anthem's early and consistent support of women throughout the entirety of their maternal health journey with solutions such as ongoing education, case management, and care coordination.

    Every day, women face many different stressors in both their personal and professional lives. Key findings in the National Center for Health Statistics (NCHS) Data Brief show women were almost twice as likely as men (10.4% vs. 5.5%) to have had depression. And research by the Centers for Disease Control and Prevention shows that about 1 in 8 women experience symptoms of postpartum depression.

    "As a mother to three, I felt what all moms feel – that pregnancy is a roller coaster ride, from preconception to postpartum care," said Bryony Winn, President, Health Solutions at Anthem, Inc. "Our partnership with Happify is about improving every aspect of the pregnancy experience – whether it pertains to physical or behavioral health – and meeting all the various needs of moms."

    Happify Health's approach is anchored in Sequences, which are digital experiences configured to support specific medical conditions. Sequences weave together, in one unified platform, components like evidence-based digital therapeutics, online communities, coaching, and localized resources, with care recommendations tailored for each individual. They are open by design and can integrate with existing systems and point solutions, with members able to seamlessly navigate to the offering that suits their needs.

    Anthem is collaborating with Happify Health to develop a Sequence focused on maternal health. Eligible members of Anthem's affiliated health plans in select markets will have access to Happify Health's online pregnancy community, where they can connect with mental health experts, obstetrics, and gynecology experts, dietitians, and other healthcare professionals, ask questions, and discuss their physical challenges, and develop meaningful connections with others dealing with similar health issues. Eligible members will also have access to Happify Health's evidence-based digital therapeutics, including a new non-prescription digital therapeutic addressing mental health needs during pregnancy.

    "We are thrilled to partner with Anthem and continue to support women's health journeys and ultimately create better health outcomes," said Ofer Leidner, President of Happify Health. "Many of Anthem's affiliated health plan members will have access to personalized, science-based care solutions to improve health and well-being across the continuum of the care journey—from digital therapeutics and coaching to community support."

    Anthem intends to make the Happify Health Pregnancy Sequence available to eligible members in its affiliated health plans in select markets toward the end of this year.

    About Anthem, Inc.

    Anthem, which will become Elevance Health on June 28, 2022, is a leading health company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves approximately 118 million people, including nearly 47 million within its family of health plans. Delivering health beyond healthcare, Anthem is expanding from being a partner in health benefits to a lifetime, trusted health partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.

    About Happify Health

    Happify Health is The Intelligent Healing Company™. We shorten the distance between need and care by configuring personalized digital therapeutics and care solutions at scale for the modern healthcare cloud. Our platform integrates AI with empathy, making healing more personal, precise, and connected for the entire care journey. We deploy a full spectrum of clinical-grade care solutions—including Digital Therapeutics, Coaching, Community, and Well-being products—for pharma, health plans, enterprises, and individuals everywhere. For more information, visit HappifyHealth.com. Our global platform is available in 10 languages, supports chronic conditions, and covers more than 18 million lives.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220607005042/en/

    Get the next $ANTM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ANTM

    DatePrice TargetRatingAnalyst
    6/22/2022$607.00 → $533.00Overweight → Equal-Weight
    Morgan Stanley
    6/17/2022$550.00Buy
    Loop Capital
    5/27/2022$577.00 → $596.00Outperform
    Bernstein
    2/7/2022$475.00 → $500.00Buy
    Argus Research
    1/28/2022$561.00 → $518.00Overweight
    Morgan Stanley
    1/27/2022$430.00 → $465.00Market Perform
    SVB Leerink
    12/20/2021$450.00 → $510.00Neutral → Buy
    Mizuho
    12/17/2021$486.00 → $561.00Overweight
    Morgan Stanley
    More analyst ratings

    $ANTM
    Financials

    Live finance-specific insights

    See more
    • Anthem, Inc. Completes Acquisition of Integra Managed Care

      Anthem, Inc. (NYSE:ANTM) today announced the completion of its acquisition of Integra Managed Care, a Managed Long-Term Care Plan in New York that helps adults with long term care needs and disabilities live safely and independently in their own home. "We're pleased to complete this acquisition and work alongside our new colleagues as we continue to grow our Medicaid business and enhance the healthcare experience for all of our members," said Felicia Norwood, Executive Vice President of Anthem's Government Business Division. "Anthem and Integra's shared commitment to deliver high quality, comprehensive whole-health care across communities throughout New York ensures that our members will c

      5/5/22 7:48:00 AM ET
      $ANTM
      Medical Specialities
      Health Care
    • Anthem Reports First Quarter 2022 Results, Reflecting Strong Momentum Across All Divisions

      First quarter GAAP net income was $7.39 per share, including net negative adjustment items of $0.86 per share. Adjusted net income was $8.25* per share. Operating revenue grew by 18.0% over the prior year quarter to $37.9 billion. Operating gain grew by 13.2% over the prior year quarter to $2.4 billion. Medical enrollment increased by 3.3 million members year-over-year and 1.4 million members sequentially to 46.8 million members. Second quarter 2022 dividend of $1.28 per share declared to shareholders. Anthem, Inc. (NYSE:ANTM) reported first quarter 2022 results reflecting strong financial performance, including double-digit top and bottom line growth. "Our strong momentum a

      4/20/22 6:00:00 AM ET
      $ANTM
      Medical Specialities
      Health Care
    • Anthem to Hold Conference Call and Webcast to Discuss First Quarter Results on April 20, 2022

      Anthem, Inc. (NYSE:ANTM) will release first quarter 2022 financial results on April 20, 2022, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 800-813-5525 (Domestic Replay) 312-470-0178 (International) 203-369-3346 (International Replay) The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on April 20, 2022 until the end of the day on May 20, 2022. The cal

      4/6/22 4:05:00 PM ET
      $ANTM
      Medical Specialities
      Health Care

    $ANTM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Anthem Inc. (Amendment)

      SC 13G/A - Anthem, Inc. (0001156039) (Subject)

      2/9/22 3:24:47 PM ET
      $ANTM
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Anthem, Inc. (0001156039) (Subject)

      2/10/21 10:30:29 AM ET
      $ANTM
      Medical Specialities
      Health Care

    $ANTM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Anthem Announces Subsidiary Brands Under Elevance Health

      Changes reflect the company's continued evolution to support whole health As Anthem, Inc. (ANTM) moves closer to rebranding to Elevance Health, Inc. later this month, the company today announced the launch of healthcare services brand Carelon and health plan brand Wellpoint to join the company's family of brands that includes Anthem Blue Cross and Blue Shield. The move will optimize and streamline the company's brand portfolio, reduce complexities, and further underscore its evolution to deliver solutions beyond traditional health insurance, simplify the healthcare experience, and advance health beyond healthcare. "An important part of being a lifetime, trusted health partner is grounded

      6/15/22 10:00:00 AM ET
      $ANTM
      Medical Specialities
      Health Care
    • Anthem, Inc. Aims to Enhance Maternal Health with New Digital-First Solution

      Anthem partners with Happify Health to bring innovative digital health services to areas of women's health including pregnancy, menopause, and more Anthem, Inc. (NYSE:ANTM), a leading health company dedicated to improving lives and communities, will add to its ongoing support of the whole health of women with the addition of a new a digital-first solution in select markets. This program, a collaboration between Anthem – soon to be Elevance Health on June 28 – and Happify Health, bridges the gap between the unique physical and mental health concerns women face. It is part of Anthem's early and consistent support of women throughout the entirety of their maternal health journey with solution

      6/7/22 7:55:00 AM ET
      $ANTM
      Medical Specialities
      Health Care
    • Anthem Announces Appearance at Upcoming Conference

      Anthem, Inc. (NYSE:ANTM) announced today that senior management is scheduled to present at the 38th Annual Bernstein Strategic Decisions Conference in New York City on June 3, at 8:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a webcast of the presentation by visiting www.antheminc.com and selecting the "Investors" link. Following the presentation, a webcast replay will be available for two weeks. To listen to the live webcast, please visit Anthem's website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the presentations will be presumed to have read Anthem's most recent filings with the SEC,

      5/26/22 4:05:00 PM ET
      $ANTM
      Medical Specialities
      Health Care

    $ANTM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Anthem downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Anthem from Overweight to Equal-Weight and set a new price target of $533.00 from $607.00 previously

      6/22/22 7:17:32 AM ET
      $ANTM
      Medical Specialities
      Health Care
    • Loop Capital initiated coverage on Anthem with a new price target

      Loop Capital initiated coverage of Anthem with a rating of Buy and set a new price target of $550.00

      6/17/22 7:14:30 AM ET
      $ANTM
      Medical Specialities
      Health Care
    • Bernstein resumed coverage on Anthem with a new price target

      Bernstein resumed coverage of Anthem with a rating of Outperform and set a new price target of $596.00 from $577.00 previously

      5/27/22 7:11:36 AM ET
      $ANTM
      Medical Specialities
      Health Care

    $ANTM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Todt Blair Williams was granted 3,983 shares, increasing direct ownership by 93% to 8,283 units

      4 - Elevance Health, Inc. (0001156039) (Issuer)

      1/5/23 5:03:57 PM ET
      $ANTM
      Medical Specialities
      Health Care
    • SEC Form 4: Norwood Felicia F covered exercise/tax liability with 1,754 shares, decreasing direct ownership by 6% to 26,684 units

      4 - Elevance Health, Inc. (0001156039) (Issuer)

      1/4/23 4:50:33 PM ET
      $ANTM
      Medical Specialities
      Health Care
    • SEC Form 4: Todt Blair Williams covered exercise/tax liability with 117 shares, decreasing direct ownership by 3% to 4,300 units

      4 - Elevance Health, Inc. (0001156039) (Issuer)

      12/5/22 4:53:39 PM ET
      $ANTM
      Medical Specialities
      Health Care

    $ANTM
    SEC Filings

    See more
    • Anthem Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Elevance Health, Inc. (0001156039) (Filer)

      11/4/22 4:16:09 PM ET
      $ANTM
      Medical Specialities
      Health Care
    • SEC Form 424B3 filed by Anthem Inc.

      424B3 - Elevance Health, Inc. (0001156039) (Filer)

      10/27/22 4:22:42 PM ET
      $ANTM
      Medical Specialities
      Health Care
    • SEC Form FWP filed by Anthem Inc.

      FWP - Elevance Health, Inc. (0001156039) (Subject)

      10/26/22 5:22:59 PM ET
      $ANTM
      Medical Specialities
      Health Care

    $ANTM
    Leadership Updates

    Live Leadership Updates

    See more
    • Treace Medical Concepts Appoints New Directors

      PONTE VEDRA, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today announced the appointment of Betsy Hanna and Deepti Jain to its Board of Directors effective October 1, 2021. "With decades of combined experience in healthcare leadership, Ms. Hanna and Ms. Jain strengthen the expertise of our Company's Board of Directors," said James T. Treace, the Company's Chairman of the Board. "Our executive leadership and board are pleased to add two individuals with their stellar reputa

      10/4/21 8:00:00 AM ET
      $ANTM
      $TCMD
      $TMCI
      Medical Specialities
      Health Care
      Medical/Dental Instruments
    • David P. Abney, Gail K. Boudreaux Named to Target Corporation's Board of Directors

      MINNEAPOLIS, Aug. 11, 2021 /PRNewswire/ -- Target Corporation (NYSE:TGT) announced today its board of directors elected David P. Abney, former chairman of the board and chief executive officer of United Parcel Service, Inc., and Gail K. Boudreaux, president and chief executive officer of Anthem, Inc., as directors. Mr. Abney's appointment is effective immediately and Ms. Boudreaux's appointment becomes effective September 23, 2021. Mr. Abney, 65, held a series of escalating leadership roles at UPS over his more than 40-year career. He was named CEO in September 2014 and chairman and CEO in February 2016, a role he held until announcing his retirement in June 2020. He remained executive chair

      8/11/21 4:05:00 PM ET
      $ANTM
      $TGT
      Medical Specialities
      Health Care
      Department/Specialty Retail Stores
      Consumer Discretionary
    • Dante Labs Announces Appointment of Healthcare Veteran and GRAIL SVP Mark Morgan to Board Of Directors to Support Genomic and Precision Medicine Scaling in the United States

      CAMBRIDGE, United Kingdom, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announced today the appointment of Mark Morgan as a board member. Mark is the SVP of Market Access for GRAIL, which has developed a highly innovative multi-cancer, early detection blood test. "We are excited to welcome Mark Morgan to the Dante Labs Board," said Dante Labs CEO Andrea Riposati, "Mark is a rockstar in healthcare. His deep experience with health plans, coupled with market access expertise in both biopharma and diagnostics will be invaluable to Dante Labs as we continue to build on our global success and expansion in the United States." Mr. Morgan state

      8/9/21 7:39:23 AM ET
      $AMGN
      $ANTM
      $ILMN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Medical Specialities